Format

Send to

Choose Destination

See 1 citation found by title matching your search:

JAMA Oncol. 2019 May 1;5(5):607-608. doi: 10.1001/jamaoncol.2019.0093.

US Food and Drug Administration Approval of New Drugs Based on Noninferiority Trials in Oncology: A Dangerous Precedent?

Author information

1
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Supplemental Content

Loading ...
Support Center